Kannalife eyes share float to fund cannabis-based medicine

(Reuters) - Kannalife Sciences Inc is considering an initial public offering this year to fund development of a cannabis-based treatment for a brain disorder that affects 200,000 Americans, its chief executive said.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro